Deferred Tax Assets, Valuation Allowance of Inhibitor Therapeutics, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Inhibitor Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Inhibitor Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $6,293,356, a 15% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Inhibitor Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $6,293,356 +$839,863 +15% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $5,453,493 +$721,878 +15% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $4,731,615 -$2,908,318 -38% 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q4 2021 $7,639,933 +$58,439 +0.77% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $7,581,494 +$43,971 +0.58% 31 Dec 2020 10-K 26 Mar 2021 2020 FY
Q4 2019 $7,537,523 +$646,854 +9.4% 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q4 2018 $6,890,669 +$1,167,907 +20% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q4 2017 $5,722,762 -$421,879 -6.9% 31 Dec 2017 10-K 07 Mar 2019 2018 FY
Q4 2016 $6,144,641 +$2,547,351 +71% 31 Dec 2016 10-K 16 Feb 2018 2017 FY
Q4 2015 $3,597,290 +$1,432,582 +66% 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q4 2014 $2,164,708 +$1,407,925 +186% 31 Dec 2014 10-K 01 Feb 2016 2015 FY
Q4 2013 $756,783 -$15,290,400 -95% 31 Dec 2013 10-K 13 Feb 2015 2014 FY
Q4 2012 $16,047,183 31 Dec 2012 10-K 15 Apr 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.